mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.8 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
-0.0093 |
0.8 |